Skip to main content

Pharma Courses

Required for Senior Research Scientist I-CADD in AMRI

For more than 20 years, as Albany Molecular Research Inc. (AMRI), we have provided fully integrated drug discovery, development and manufacturing services – all while adapting to the rapidly changing needs of our customers within the pharmaceutical, biotechnology and related industries.
With locations in the United States, Europe and Asia, AMRI SMARTSOURCING™ offers you a versatile and strategic way of partnering with us that is designed to deliver reduced risk, greater flexibility and a better return on investment. AMRI has successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development.

Post: Senior Research Scientist I-CADD - (2244)

Researchers at the University of Tokyo have discovered a long-overlooked process important for converting a long, string-like DNA molecule into a chromosome. This finding gives us a better understanding of the mechanism of how cells store safely genetic material, DNA.

Shri J P Nadda, Minister of Health and Family Welfare held a review meeting with senior officials of Health Ministry in the backdrop of recent outbreak of Japanese Encephalitis (JE) in Assam. He stated that the Director General of Health Services has been directed to immediately rush a team of experts to Assam to assist and advise the State health authorities in clinical management of the cases.

Biogen and the Parkinson’s Institute and Clinical Center announced the formation of a strategic alliance focused on enhancing the understanding of the underlying biology of Parkinson’s disease (PD) and the creation of novel tools and programs that could accelerate research and the development of new PD treatments. The agreement will combine the unique clinical expertise and data of the Institute with Biogen’s focus on neurodegenerative disease and approach to clinical development.

Boehringer Ingelheim and Hanmi Pharmaceutical Co. Ltd today announced an exclusive license and collaboration agreement for the development and global commercialisation rights, except South Korea, China and Hong Kong, of HM61713, a novel 3rd generation EGFR targeted therapy for the treatment of EGFR mutation positive lung cancer. Under the terms of the agreement Hanmi will receive an initial payment of USD 50 million and is entitled to potential milestone payments of USD 680 million plus tiered double-digit royalties on future net sales. The agreement is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act, similar requirements outside the U.S., and other customary closing conditions.

Applications are invited from M.Pharm for the position of Junior Research Fellow (JRF) at SPP School of Pharmacy & Technology Management, SVKM’s NMIMS

Applications are invited for the position of Junior Research Fellow (JRF) for Central Council for Research in Unani Medicine (CCRUM), Ministry of AYUSH, Government of India, sponsored project at SPP School of Pharmacy & Technology Management, SVKM’s NMIMS, Mumbai.

Post: Junior Research Fellow (JRF)

Walk in interview for Assistant Professor in Global College of Pharmacy

The interview will be held for appointment to the post of Assistant Professor at Global College of Pharmacy at the above address. The appointments will be on contractual basis and the tenure of the appointment will be initially for a period of one year from the date of appointment which can be extended from time to time depending on performance.

Post: Assistant Professor

Requirement for Regional Manager (2nd line) in Leading Pharma Company- Nextus

Nextus is a dynamic organization offering Strategic Management & HR Consulting Solutions. We offer a range of services covering Business Consultancy, Communication Planning, Recruitment & Training. With a focused Pharmaceutical & Healthcare Industry Practice, Nextus is one of fastest growing Strategic Business Consultancy companies in India, with comprehensive Recruitment & Training solutions. We bring deep, functional expertise to focus on client’s critical issues and opportunities. Our systematic and result-oriented approach helps our clients achieve their goals in cost-effective and timely manner.

Post: Regional Manager (2nd line)

Job in Aspiring Solutions hiring for Leading API Mfg Co. for the post of Manager-Industrial Relations

Our client is the world’s second largest Integrated manufacturer of Ephedrine and Pseudo ephedrine salts. Our client's manufacturing facility at Mahad has been audited and approved by the Australian TGA, and the US FDA

Post: Manager-Industrial Relations (Male Candidate, 1 Nos.)

Career as Store Keeper in Malabar Cancer Centre

Malabar Cancer Centre, Thalassery (MCC) is an autonomous institution under Health and Family Welfare Department, Government of Kerala, started with an aim to establish a comprehensive cancer centre, providing the much-required oncology care to the population of Northern region of Kerala and neighbouring parts of Karnataka and Tamilnadu states. The main objective of the centre is not only to provide comprehensive cancer care but also to develop as a Research and Training Centre of international standards. A society named Malabar Cancer Centre Society was registered under Societies Registration Act XXI of 1860 with the above aims and clinical work in MCC started from March 2001 onwards. At present MCC has around 110 in-patient bed strength which is expected to be increased to 220 in near future.

Post: Store Keeper

Allergan plc, a leading global pharmaceutical company, and Naurex Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging disorders of the central nervous system, today announced that they have entered into a definitive agreement under which Allergan will acquire Naurex in an all-cash transaction. Under the terms of the agreement, Allergan will acquire Naurex for a $560 million upfront payment net of cash acquired, $460 million of which is payable upon the closing of the acquisition and $100 million of which is payable by January of 2016 (or upon the closing if the closing has not occurred by such time), as well as potential R&D success-based and sales-threshold milestone payments. The Company remains committed to de-leveraging to below 3.5x debt-to-EBITDA by the end of the first quarter of 2016.

Pharma Major Lupin Limited (Lupin) has entered into a strategic asset purchase agreement with TEMMLER PHARMA GMBH & CO. KG (Temmler), a part of the Aenova Group, one of the world’s largest pharmaceutical contract manufacturers, to acquire Temmler's specialty product portfolio subject to certain closing conditions.

Required for Consultant-Quality Improvement in National Health Systems Resource Centre | B.Pharm

National Health Systems Resource Centre (NHSRC) has been set up under the National Health Mission (NHM) as an autonomous registered society, to channelize technical assistance and capacity building support to the states for strengthening the public health system. The NHSRC is also mandated to contribute towards National strategic health planning and programme design. Work at the NHSRC is organised around eight divisions, namely – Community Processes, Quality Improvement, Public Health Planning, Public Health Administration, Healthcare Financing & Healthcare Technology, HMIS and Human Resources for Health.

NHSRC intends recruiting Consultant - Quality Improvement purely on contractual basis.

Post: Consultant-Quality Improvement

Vacancy as Officer / Executive – Formulation Development in Sun Pharma

Sun Pharma ranks amongst India's largest pharma companies We’ve built a reputation for speciality therapy leadership and faster- than-industry growth over the last 30 years. From a modest beginning with five people, our team today exceeds 13,000 and growing, put manufacturing base now spans 25 sites across the world. With a market cap of over $ 16 billion, we’re also India’s most valued pharma brand. To keep pace with our growth plans, we require for our Formulation manufacturing plant at Halol (Near Baroda):

Post: Officer / Executive – Formulation Development

Career opportunity for Senior Manager of Asia Contract Manufacturing in Merck

At Merck, you'll find rewarding opportunities, diverse experiences and an unwavering commitment to ethics and integrity. As part of our global team, you'll collaborate with talented and dedicated colleagues whose sense of purpose complements your own.
Whatever your career path — whether it's research, sales, marketing, manufacturing, supply, IT, policy, or supporting our business in another way — Merck offers opportunities to develop and expand your career while making a true difference in people's lives.

Post: Senior Manager of Asia Contract Manufacturing (91524)

Opportunity for Associate Manager II Data Management in Novartis

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post: Assoc Mgr II Data Mgmt

Global Green Nanotechnology Conclave (GiGaNTiC 2015)

Global Green Nanotechnology Conclave (GiGaNTiC 2015)
Focus areas are: 1) Pharma & Biotechnology; 2) Advanced materials for various industrial applications theme
"Fostering Innovation to build core competency and provide market leadership for sustainable growth”


Great platform to showcase and commercialize your products/services to MD & CEOs of the various companies, technologists, scientists, academicians, policy makers and end-users.

Dear Sir/Madam,

I’m pleased to inform you that, CII-Gujarat Centre of Excellence in Nanotechnology is organizing “Global Green Nanotechnology Conclave (GiGaNTiC 2015)” with the theme “Fostering Innovation to build core competency and provide market leadership for sustainable growth” on 6-7th August, 2015 atAhmedabad, India. Department of Science & Technology (DST) Government of India, Department of Electronics & InformationTechnology (DeitY) and Gujarat Council on Science and Technology(GUJCOST), DST, Government of Gujarat have kindly agreed to support CII in organizing the Nanotechnology Conclave. This conclave will be having Conference + Exhibition + Panel Discussion + Workshop.

Opportunities for business networking: Some of the confirmed participation from Tata Chemicals, TCS, Cadila Pharma, Zydus Cadila, Sun Pharma, Dr. Reddy’s, Torrent Pharma, Lupin, Elecon Ltd., Arvind Ltd., Admat Innovations, Zydex Industries, USV Ltd., I-Can-Nano, Aarshadhaatu, Nualgi Nanobiotech, Advance solutions, Bharat Petroleum, Jay Chemicals, Asian Granito, Continental Carbon, Eesavyasa Technologies, Ants Ceramics, InventyS, Fujifilm Sonosite, etc.

Opportunities to connect with R&D institutes, Universities & Labs for collaborative research & development projects.

I am writing to request your kind participation and also nominate colleagues from your organization at this conference of national importance by filling up the registration form. Kindly send the completed registration form along with payment by fax / courier / email to us. Detailed brochure isattached herewith for your kind reference. I am sure that your presence and participation would add great value to the conclave.

For Delegates from Universities / Academics, we are offering 1+1 free for delegate registration based on first come first serve .  Look forward for your kind confirmation.

For more information, kindly click on the following link: http://cii.in/EventsDetails.aspx?id=E000025736

Please feel free to call me if you have any query.

Kindly contact us for group discount

Session Details

Day 1: 6th August, 2015

Day 2: 7th August, 2015

1000 – 1130 Hrs: Inauguration Session

1150 – 1310 Hrs: Plenary Session-1 (Designing of Green Nanomaterials for New-age Industries: Its Easier thanYouThink)

1400 – 1530 Hrs: Plenary Session 2 (Nanotechnology applications in Healthcare)

1600 – 1730 Hrs: Plenary Session 3 (The Pathway to commercialization of Nanomedicines: Pre-clinical,clinical,quality, scale-up, manufacturing and regulatory dossiers and approvals)

1000 – 1130 Hrs: Plenary Session 4: Fabrication and characterization of advanced nanomaterials forvariousIndustrial applications - I

1150 – 1310 Hrs: Plenary Session 5: Fabrication and characterization of advanced nanomaterials forvariousIndustrial applications – II

1400 – 1530 Hrs: Panel Discussion (Theme: Nanotechnology for providing market leadershipandachieving sustainable market growth: Opportunities, challenges, policies and the way forward)

1600 – 1730 Hrs: Workshop on Advanced characterization techniques for nanomaterials

Confirmed / Invited speakers

Shri Saurabhbhai Patel; Minister-Industries & Mines, Govt. of Gujarat

Mr. R Mukundan; Managing Director, Tata Chemicals Ltd

Dr. Y. S. Rajan; Hon Distinguished Professor, ISRO

Dr. G Sundararajan; Director, ARCI, Hyderabad

Dr. Praveer Asthana; Mission Director, Nanomission, DST, GOI

Dr. M O Garg; Director General, CSIR, New Delhi

Dr. G N Singh; DCGI, New Delhi

Dr. B. S. Chakraborty; Senior vice president & Chair, Cadila Pharma

Professor Harish Padh; Vice Chancellor, Sardar Patel University

Dr. R. P. Singh; Chair Nanotechnology, Amity University

Dr. Mukul Jain; Senior Vice President, Zydus Cadila

Dr. Ajay Khopade; Vice-President, SPARC, Sun Pharmaceuticals Ltd.

Professor Alok Dhawan; Director, Institute of Life Sciences, Ahmedabad Univ.

Dr. H. Purushotham; Chairman & Managing Director, NRDC

Dr. Arup Chatterjee; CEO, I-Can Nano

Mr. R B Karthik Aamanchi; Executive Director, Aarshadhaatu Green Nanotechnologies

MrManoj Bhataria; ‎Head - AdvanceMachines, Inventys Research Company Pvt Ltd.

Dr. Ajay Ranka; CEO, Zydex Industries Ltd., Vadodara, Gujarat.

Professor Ashok K Ganguli; Director, INST, Mohali

Professor Ashok M. Raichur; Indian Institute of Science, Bangalore

Mr. D. P. Chakravarthy; MD, Eesavyasa Technologies Pvt. Ltd.

Mr. Sampath Kumar Thothathri; CEO, Nualgi Nanobiotech

Mr. Mihir Joshi; CEO, Gujarat Venture Financial Ltd.

Mr. P Siva Prasad; CEO, Analytical Technologies

For further details, Please contact:
Gaurang Patel
Centre of Excellence in Nanotechnology (CoE-NT)
Confederation of Indian Industry, CII House, GulbaiTekra Road, Near Panchvati, Ahmedabad - 380 006
Email: gaurang.patel@cii.in
Contact No.: 08460464349

Subscribe to